Alison L. Harte

4.8k total citations · 2 hit papers
36 papers, 3.9k citations indexed

About

Alison L. Harte is a scholar working on Epidemiology, Physiology and Endocrine and Autonomic Systems. According to data from OpenAlex, Alison L. Harte has authored 36 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 17 papers in Physiology and 6 papers in Endocrine and Autonomic Systems. Recurrent topics in Alison L. Harte's work include Adipokines, Inflammation, and Metabolic Diseases (21 papers), Adipose Tissue and Metabolism (15 papers) and Regulation of Appetite and Obesity (6 papers). Alison L. Harte is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (21 papers), Adipose Tissue and Metabolism (15 papers) and Regulation of Appetite and Obesity (6 papers). Alison L. Harte collaborates with scholars based in United Kingdom, Saudi Arabia and Egypt. Alison L. Harte's co-authors include Philip G. McTernan, Sudhesh Kumar, Nancy F. da Silva, S. J. Creely, Christine M. Kusminski, Manish Khanolkar, Mari Evans, Gyanendra Tripathi, Nasser M. Al‐Daghri and Adam Baker and has published in prestigious journals such as Circulation, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Alison L. Harte

36 papers receiving 3.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes

2006 808 citations S. J. Creely, Philip G. McTernan et al. American Journal of Physiology-Endocrinology and Metabolism profile →
Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease

2006 539 citations Adam Baker, Nancy F. da Silva et al. Cardiovascular Diabetology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alison L. Harte United Kingdom	28	1.8k	1.6k	1.2k	816	600	36	3.9k
Vanessa van Harmelen Netherlands	37	2.4k 1.3×	1.5k 0.9×	1.5k 1.2×	704 0.9×	766 1.3×	73	4.7k
Bernard E. Bihain France	27	1.5k 0.8×	1.5k 0.9×	918 0.8×	529 0.6×	617 1.0×	53	4.0k
Gouri Ranganathan United States	25	1.7k 1.0×	2.0k 1.3×	1.1k 0.9×	692 0.8×	352 0.6×	44	4.1k
Vladimír Štich Czechia	40	2.9k 1.6×	1.9k 1.2×	898 0.8×	971 1.2×	533 0.9×	108	4.7k
Margaret F. Gregor United States	7	1.7k 0.9×	1.8k 1.1×	1.1k 0.9×	364 0.4×	631 1.1×	8	4.3k
Neda Rasouli United States	37	2.3k 1.3×	2.2k 1.4×	1.7k 1.4×	943 1.2×	697 1.2×	92	5.5k
Andreas Oberbach Germany	26	2.2k 1.2×	1.6k 1.0×	1.9k 1.6×	689 0.8×	578 1.0×	80	5.2k
Mustapha Maachi France	18	1.4k 0.8×	1.9k 1.2×	895 0.7×	445 0.5×	339 0.6×	34	4.4k
José E. Galgani Chile	29	2.2k 1.2×	1.3k 0.8×	1.8k 1.5×	457 0.6×	479 0.8×	91	4.9k
Jesse J. Lugus United States	10	1.5k 0.8×	1.9k 1.2×	1.6k 1.3×	684 0.8×	309 0.5×	11	4.4k

Countries citing papers authored by Alison L. Harte

Since Specialization

Citations

This map shows the geographic impact of Alison L. Harte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison L. Harte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison L. Harte more than expected).

Fields of papers citing papers by Alison L. Harte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison L. Harte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison L. Harte. The network helps show where Alison L. Harte may publish in the future.

Co-authorship network of co-authors of Alison L. Harte

This figure shows the co-authorship network connecting the top 25 collaborators of Alison L. Harte. A scholar is included among the top collaborators of Alison L. Harte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison L. Harte. Alison L. Harte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Piya, Milan K., Alison L. Harte, & Philip G. McTernan. (2013). Metabolic endotoxaemia. Current Opinion in Lipidology. 24(1). 78–85. 71 indexed citations

Voyias, Philip, Kirsty McGee, Alison L. Harte, et al.. (2012). Expression of genes regulating mitochondrial fusion and fission in human adipose tissue are influenced by adiposity and bariatric surgery. WestminsterResearch (University of Westminster). 1 indexed citations

Al‐Daghri, Nasser M., Omar S. Al‐Attas, Tahia H. Saleem, et al.. (2012). Increased Circulating ANG II and TNF-α Represents Important Risk Factors in Obese Saudi Adults with Hypertension Irrespective of Diabetic Status and BMI. PLoS ONE. 7(12). e51255–e51255. 7 indexed citations

Schisano, Bruno, Alison L. Harte, Konstantinos Lois, et al.. (2011). GLP-1 analogue, Liraglutide protects human umbilical vein endothelial cells against high glucose induced endoplasmic reticulum stress. Regulatory Peptides. 174(1-3). 46–52. 75 indexed citations

McGee, Kirsty, Gyanendra Tripathi, Nasser M. Al‐Daghri, et al.. (2011). Acute and chronic saturated fatty acid treatment as a key instigator of the TLR-mediated inflammatory response in human adipose tissue, in vitro. The Journal of Nutritional Biochemistry. 23(1). 39–50. 53 indexed citations

McGee, Kirsty, Alison L. Harte, Nancy F. da Silva, et al.. (2011). Visfatin Is Regulated by Rosiglitazone in Type 2 Diabetes Mellitus and Influenced by NFκB and JNK in Human Abdominal Subcutaneous Adipocytes. PLoS ONE. 6(6). e20287–e20287. 34 indexed citations

Al‐Attas, Omar S., Nasser M. Al‐Daghri, Majed S. Alokail, et al.. (2010). Adiposity and insulin resistance correlate with telomere length in middle-aged Arabs: the influence of circulating adiponectin. European Journal of Endocrinology. 163(4). 601–607. 68 indexed citations

Harte, Alison L., Nancy F. da Silva, S. J. Creely, et al.. (2010). Elevated endotoxin levels in non-alcoholic fatty liver disease. Journal of Inflammation. 7(1). 15–15. 316 indexed citations

Kos, Katarina, Andrew H. Baker, Margareta Jernås, et al.. (2009). DPP‐IV inhibition enhances the antilipolytic action of NPY in human adipose tissue. Diabetes Obesity and Metabolism. 11(4). 285–292. 67 indexed citations

10.

Al‐Attas, Omar S., Nasser M. Al‐Daghri, Khalid Al‐Rubeaan, et al.. (2009). Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies. Cardiovascular Diabetology. 8(1). 20–20. 116 indexed citations

11.

Dixon, Anthony, George Valsamakis, Alison L. Harte, et al.. (2008). Effect of the orlistat on serum endotoxin lipopolysaccharide and adipocytokines in South Asian individuals with impaired glucose tolerance. International Journal of Clinical Practice. 62(7). 1124–1129. 24 indexed citations

12.

Miller, Michelle A., Philip G. McTernan, Alison L. Harte, et al.. (2008). Ethnic and sex differences in circulating endotoxin levels: A novel marker of atherosclerotic and cardiovascular risk in a British multi-ethnic population. Atherosclerosis. 203(2). 494–502. 81 indexed citations

13.

Kos, Katarina, Alison L. Harte, Paul O’Hare, Sudhesh Kumar, & Philip G. McTernan. (2008). Ghrelin and the differential regulation of des‐acyl (DSG) and oct‐anoyl ghrelin (OTG) in human adipose tissue (AT). Clinical Endocrinology. 70(3). 383–389. 30 indexed citations

14.

Gupta, Pratima, Alison L. Harte, Nancy F. da Silva, et al.. (2007). Expression of calcitonin gene-related peptide, adrenomedullin, and receptor modifying proteins in human adipose tissue and alteration in their expression with menopause status. Menopause The Journal of The North American Menopause Society. 14(6). 1031–1038. 21 indexed citations

15.

Kos, Katarina, Alison L. Harte, Sean James, et al.. (2007). Secretion of neuropeptide Y in human adipose tissue and its role in maintenance of adipose tissue mass. American Journal of Physiology-Endocrinology and Metabolism. 293(5). E1335–E1340. 75 indexed citations

16.

Kos, Katarina, Alison L. Harte, Nancy F. da Silva, et al.. (2007). Adiponectin and Resistin in Human Cerebrospinal Fluid and Expression of Adiponectin Receptors in the Human Hypothalamus. The Journal of Clinical Endocrinology & Metabolism. 92(3). 1129–1136. 184 indexed citations

17.

Baker, Adam, Nancy F. da Silva, Alison L. Harte, et al.. (2006). Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovascular Diabetology. 5(1). 1–1. 539 indexed citations breakdown →

18.

Harte, Alison L., Philip G. McTernan, C. L. McTernan, et al.. (2003). Insulin increases angiotensinogen expression in human abdominal subcutaneous adipocytes. Diabetes Obesity and Metabolism. 5(6). 462–467. 32 indexed citations

19.

Harte, Alison L., et al.. (2003). Rosiglitazone inhibits the insulin‐mediated increase in PAI‐1 secretion in human abdominal subcutaneous adipocytes. Diabetes Obesity and Metabolism. 5(5). 302–310. 42 indexed citations

20.

McTernan, Philip G., et al.. (2002). The regulation of HSL and LPL expression by DHT and flutamide in human subcutaneous adipose tissue. Diabetes Obesity and Metabolism. 4(3). 209–213. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact